Robert S. Landsman

Array ( [id] => 10887970 [patent_doc_number] => 08911964 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-12-16 [patent_title] => 'Fed-batch method of making human anti-TNF-alpha antibody' [patent_app_type] => utility [patent_app_number] => 14/226579 [patent_app_country] => US [patent_app_date] => 2014-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 47179 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 104 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14226579 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9616183 [patent_doc_number] => 20140206038 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-07-24 [patent_title] => 'CELL CULTURE IMPROVEMENTS' [patent_app_type] => utility [patent_app_number] => 14/226333 [patent_app_country] => US [patent_app_date] => 2014-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 46842 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14226333 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10926258 [patent_doc_number] => 20140329278 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-11-06 [patent_title] => 'AMINO ACID SEQUENCES DIRECTED AGAINST IL-6R AND POLYPEPTIDES COMPRISING THE SAME FOR THE TREATMENT OF IL-6R RELATED DISEASES AND DISORDERS' [patent_app_type] => utility [patent_app_number] => 14/221389 [patent_app_country] => US [patent_app_date] => 2014-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 90 [patent_figures_cnt] => 90 [patent_no_of_words] => 91034 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14221389 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10548538 [patent_doc_number] => 09273150 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-03-01 [patent_title] => 'Methods of using IL-6R antibodies to block or reduce binding of IL-6 to IL-6R' [patent_app_type] => utility [patent_app_number] => 14/221409 [patent_app_country] => US [patent_app_date] => 2014-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 90 [patent_figures_cnt] => 144 [patent_no_of_words] => 90903 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14221409 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10940237 [patent_doc_number] => 20140343257 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-11-20 [patent_title] => 'AMINO ACID SEQUENCES DIRECTED AGAINST IL-6R AND POLYPEPTIDES COMPRISING THE SAME FOR THE TREATMENT OF IL-6R RELATED DISEASES AND DISORDERS' [patent_app_type] => utility [patent_app_number] => 14/221364 [patent_app_country] => US [patent_app_date] => 2014-03-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 90 [patent_figures_cnt] => 90 [patent_no_of_words] => 91021 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14221364 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10534905 [patent_doc_number] => 09260527 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-02-16 [patent_title] => 'Anti-human CXCR4 antibodies and methods of making same' [patent_app_type] => utility [patent_app_number] => 14/217841 [patent_app_country] => US [patent_app_date] => 2014-03-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 41 [patent_figures_cnt] => 41 [patent_no_of_words] => 10802 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14217841 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10692301 [patent_doc_number] => 20160038447 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-02-11 [patent_title] => 'MODULATION OF REGULATORY T CELLS VIA G-COUPLED PROTEIN RECEPTOR 43' [patent_app_type] => utility [patent_app_number] => 14/777476 [patent_app_country] => US [patent_app_date] => 2014-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 41 [patent_figures_cnt] => 41 [patent_no_of_words] => 13146 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14777476 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10678017 [patent_doc_number] => 20160024163 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-01-28 [patent_title] => 'MODULATION OF ANGIOGENESIS AND RELATED CONDITIONS USING INHIBITORS OF G-PROTEIN-COUPLED RECEPTOR KINASE INTERACTING PROTEIN-1 (GIT1)' [patent_app_type] => utility [patent_app_number] => 14/775936 [patent_app_country] => US [patent_app_date] => 2014-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 17952 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14775936 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9757307 [patent_doc_number] => 20140288008 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-09-25 [patent_title] => 'NOVEL BINDING PROTEINS FOR PCSK9' [patent_app_type] => utility [patent_app_number] => 14/208629 [patent_app_country] => US [patent_app_date] => 2014-03-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 27389 [patent_no_of_claims] => 63 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14208629 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9735915 [patent_doc_number] => 20140271627 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-09-18 [patent_title] => 'HUMANIZED, ANTI-N2 ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 14/206316 [patent_app_country] => US [patent_app_date] => 2014-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 11095 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14206316 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10077342 [patent_doc_number] => 09115184 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-08-25 [patent_title] => 'Light-inducible system for regulating protein stability' [patent_app_type] => utility [patent_app_number] => 14/194052 [patent_app_country] => US [patent_app_date] => 2014-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 17 [patent_no_of_words] => 11510 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14194052 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9699359 [patent_doc_number] => 20140249044 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-09-04 [patent_title] => 'Cell-Based Methods for Coupling Protein Interactions and Binding Molecule Selection and Diversification' [patent_app_type] => utility [patent_app_number] => 14/193679 [patent_app_country] => US [patent_app_date] => 2014-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 29803 [patent_no_of_claims] => 169 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14193679 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11575765 [patent_doc_number] => 09631012 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-04-25 [patent_title] => 'Antibodies against TM4SF5 and methods of use thereof' [patent_app_type] => utility [patent_app_number] => 14/770317 [patent_app_country] => US [patent_app_date] => 2014-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 63 [patent_no_of_words] => 12861 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14770317 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9546101 [patent_doc_number] => 20140170750 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-06-19 [patent_title] => 'MODULATING REGULATORY T CELL ACTIVITY VIA INTERLEUKIN 35' [patent_app_type] => utility [patent_app_number] => 14/187751 [patent_app_country] => US [patent_app_date] => 2014-02-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 12779 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14187751 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9739179 [patent_doc_number] => 20140274898 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-09-18 [patent_title] => 'HAIR GROWTH METHODS USING FGFR3 EXTRACELLULAR DOMAINS' [patent_app_type] => utility [patent_app_number] => 14/185086 [patent_app_country] => US [patent_app_date] => 2014-02-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 14388 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14185086 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9670439 [patent_doc_number] => 20140234301 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-08-21 [patent_title] => 'Modulation of PILR to Treat Immune Disorders' [patent_app_type] => utility [patent_app_number] => 14/181488 [patent_app_country] => US [patent_app_date] => 2014-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 24066 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14181488 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10470183 [patent_doc_number] => 20150355200 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-12-10 [patent_title] => 'Method for Selecting Agents that Bind to Transmembrane Receptors in a Conformationally-Selective Manner' [patent_app_type] => utility [patent_app_number] => 14/761911 [patent_app_country] => US [patent_app_date] => 2014-02-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 19 [patent_figures_cnt] => 19 [patent_no_of_words] => 14048 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14761911 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11487092 [patent_doc_number] => 09593157 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-03-14 [patent_title] => 'Chimeric polypeptides comprising G protein-coupled receptors and VHH antibodies' [patent_app_type] => utility [patent_app_number] => 14/764548 [patent_app_country] => US [patent_app_date] => 2014-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 51 [patent_no_of_words] => 45144 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14764548 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9634324 [patent_doc_number] => 20140212432 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-07-31 [patent_title] => 'Antibodies Specific for Urokinase-Type Plasminogen Activator and Methods of Use Thereof' [patent_app_type] => utility [patent_app_number] => 14/162439 [patent_app_country] => US [patent_app_date] => 2014-01-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 25556 [patent_no_of_claims] => 56 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14162439 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9477211 [patent_doc_number] => 20140134674 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-05-15 [patent_title] => 'CELL CULTURE IMPROVEMENTS' [patent_app_type] => utility [patent_app_number] => 14/156829 [patent_app_country] => US [patent_app_date] => 2014-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 47180 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14156829 [rel_patent_id] =>[rel_patent_doc_number] =>)